Gene80321
CEP70: centrosomal protein 70
Cite this record
ConductScience Library. CEP70: centrosomal protein 70. Genes, record 80321. Release gene-search-2026-11-13-0.2.1, 13 Nov 2026. https://conductscience.org/library/genes/80321
- Sources
- 13 sources
- Release
- gene-search-2026-11-13-0.2.1
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| Q8NHQ1 | Centrosomal protein of 70 kDa | 597 | 0 | Ensembl, GeneID, HGNC |
Source UniProt
Patents70
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| US 20260193644 A1 | 2026-07-09 | 2003 | Q8NHQ1 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 40899 | Q8NHQ1 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 40903 | Q8NHQ1 | Espacenet |
| EP 4641201 A2 | 2025-10-29 | 2003 | Q8NHQ1 | Espacenet |
| JP 2025517969 A | 2025-06-12 | 2003 | Q8NHQ1 | Espacenet |
| US 20240398993 A1 | 2024-12-05 | 11438 | Q8NHQ1 | Espacenet |
| US 20240327476 A1 | 2024-10-03 | 40899 | Q8NHQ1 | Espacenet |
| US 20240327476 A1 | 2024-10-03 | 40903 | Q8NHQ1 | Espacenet |
| US 20230026259 A1 | 2023-01-26 | 14165 | Q8NHQ1 | Espacenet |
| US 20230026259 A1 | 2023-01-26 | 14172 | Q8NHQ1 | Espacenet |
NIH grants333
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | CEP70 papers | Newest fiscal year |
|---|---|---|---|
| P30CA008748 | Cancer Center Support Grant | 16 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 4 | 2025 |
| P30AI064518 | Center for AIDS Research | 3 | 2025 |
| P30CA010815 | Consolidated Basic Cancer Research Program | 3 | 2025 |
| P30CA016359 | Cancer Center Support Grant | 3 | 2025 |
| P30CA051008 | Georgetown University Lombardi Comprehensive Cancer Center Support Grant | 3 | 2025 |
| P30AI050410 | The University of North Carolina Center for AIDS Research | 2 | 2025 |
| P30CA006973 | Regional Oncology Research Center | 2 | 2025 |
| P30CA012197 | Cancer Center Support Grant | 2 | 2025 |
| P30CA016087 | Cancer Center Support Grant | 2 | 2025 |
Source NIH's project files
Papers500
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A Generalization of the Ternary Binding Model to Membrane-Confined Systems With Finite Copy Number. | CPT Pharmacometrics Syst Pharmacol | 2026 | 42663854 | PubTator, text mining | PubMed |
| In silico clinical trials of BiTE expression by oncolytic viruses reveal the impact of patient heterogeneity on dosage protocol. | PLoS Comput Biol | 2026 | 42531348 | PubTator, text mining | PubMed |
| TP53 deficiency in AML induces resistance to T-cell engagers through an immunosuppressive secretome. | Leukemia | 2026 | 42225967 | PubTator, text mining | PubMed |
| "Immunologic dream team": BiTEs periallotransplant to redirect donor lymphocytes toward GVL. | Blood Adv | 2026 | 42160762 | PubTator, text mining | PubMed |
| Single injection of modified self-amplifying RNA encoding a CD19 bispecific T cell engager mediates long-term malignant B cell clearance. | bioRxiv | 2026 | 42039561 | PubTator, text mining | PubMed |
| Analyzing Real-World Infection Risk in Multiple Myeloma Patients Receiving Teclistamab. | Curr Oncol | 2026 | 41892182 | PubTator, text mining | PubMed |
| TP53-mutated myelodysplastic syndromes and acute myeloid leukemia: a comprehensive overview of targeted approaches. | Front Oncol | 2026 | 41809820 | PubTator, text mining | PubMed |
| Unleashing the potential of bimetallic nanobomb-mediated STING pathway to enhance bispecific T-cell engager against colorectal cancer photo-immunotherapy. | Signal Transduct Target Ther | 2026 | 41781380 | PubTator, text mining | PubMed |
| Ready or not, here they come: a practical guide to adoptive T-cell therapies for solid tumors for medical oncologists. | Oncologist | 2026 | 41739670 | PubTator, text mining | PubMed |
| Bispecific and multispecific T-cell engagers: advancing the future of immunotherapy. | Antib Ther | 2026 | 41561192 | PubTator, text mining | PubMed |
None in this release
- Drugs
- Trials
Sources 13
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
- USPTO's sequence listingsPublic domain in the US. Source: United States Patent and Trademark Office, www.uspto.gov
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
- USPTO's sequence listingsUSPTO's sequence listings of patents and published applications, from its bulk data files. No license named for the files. USPTO's terms say "most government-produced materials appearing on this website are not subject to copyright restrictions within the United States and are therefore in the public domain", and ask that USPTO be given appropriate acknowledgement ("Source: United States Patent and Trademark Office, www.uspto.gov"). USPTO does not endorse ConductScience or this release. Read on 12 Nov 2026 at https://www.uspto.gov/terms-use-uspto-websites
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
Source: United States Patent and Trademark Office, www.uspto.gov. USPTO does not endorse ConductScience or this database.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/80321
GET https://conductscience.org/api/genes/v1/80321/patents?page=2